Definition of erythropenia

erythr-o-pen--ia - decreased erythrocyte volume due to decreased hematocrit (condition of red blood cell deficiency); Erythropenia (also called erythrocytopenia) is a quantifiable decrease in the number of erythrocytes (red blood cells) circulating in the peripheral blood. Because erythrocytes are responsible for carrying hemoglobin—the protein that binds and transports oxygen to tissues—a significant reduction in their numbers directly compromises tissue oxygenation, leading to hypoxia. Clinically, erythropenia is the core physiological mechanism behind anemia. The condition generally stems from one of three primary pathophysiological categories: decreased RBC production in the bone marrow (e.g., due to nutritional deficiencies or aplastic conditions), increased RBC destruction (hemolysis), or direct physical loss (hemorrhage).


Etymology of erythropenia

greek The term is constructed from two distinct Greek elements combined with a vowel:

  • erythr- (ἐρυθρός): Root meaning “red.”

  • -o-: Combining vowel used to link anatomical roots.

  • -penia (πενία): Suffix meaning “poverty,” “deficiency,” or “decrease.”

  • Literal Meaning: “Deficiency of red (blood cells).”


Coding & Documentation Nuances

  • ICD-10-CM: While “erythropenia” is a valid clinical finding, coders rarely use a specific code just for the word itself; it maps directly to Anemia, unspecified (D64.9). The coder’s goal is to query or search the documentation for the cause of the erythropenia to assign a more specific code (e.g., D50.9 for Iron deficiency anemia, D62 for Acute posthemorrhagic anemia, or D61.9 for Aplastic anemia).

  • Combination Codes: If the erythropenia is caused by chemotherapy or other antineoplastic drugs, coders must assign the specific code for the adverse effect, often leading to D64.81 (Anemia due to antineoplastic chemotherapy).

  • ICD-10-PCS Root Operations: When severe erythropenia is treated via the administration of Packed Red Blood Cells (PRBCs), the relevant PCS root operation is Transfusion (Putting in blood or blood products). A common code for this is 30233N1 (Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach).

Clinical Indicators

To support a diagnosis related to erythropenia (anemia) and any associated medical decision-making (MDM) complexity, coders should look for:

  1. Laboratory Values: A Complete Blood Count (CBC) revealing an RBC count below the standard reference range (typically < 4.3 million/mcL for men and < 3.9 million/mcL for women), often accompanied by low Hemoglobin (Hgb) and Hematocrit (Hct) levels.

  2. Physical Exam Findings: Documentation of pallor (pale skin/conjunctiva), tachycardia (rapid heart rate compensating for low oxygen), or patient complaints of severe fatigue, weakness, and dyspnea on exertion.

  3. Pharmacological/Surgical Interventions: Orders for blood transfusions, prescription of Erythropoiesis-Stimulating Agents (ESAs) like epoetin alfa (Epogen/Procrit), or targeted supplementation (IV iron, B12 injections).

  • Anemia: The broader clinical syndrome resulting from decreased oxygen-carrying capacity. Erythropenia is the literal quantitative shortage of cells that usually causes anemia.

  • Erythrocytosis / Polycythemia: The exact opposite of erythropenia; an abnormal increase in the number of circulating red blood cells.

  • Leukopenia: A deficiency in white blood cells (leukocytes), impacting the immune system rather than oxygen transport.

  • Thrombocytopenia: A deficiency in platelets (thrombocytes), leading to bleeding disorders and impaired coagulation.

  • pancytopenia: A severe hematological state characterized by a concurrent deficiency in all three major cellular components of the blood (erythropenia + leukopenia + thrombocytopenia).



Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms